Therapy-related leukemia: what is the role of 4-epi-doxorubicin?
Riggi
M
M
Riva
A
A
D015251:Epirubicin / Q000009:adverse effects*; D006801:Humans; D007938:Leukemia / Q000139:chemically induced*; D016609:Neoplasms, Second Primary / Q000139:chemically induced*
D015251:Epirubicin